Thromboxane A2 Modulates Endothelial Permeability
1994

Thromboxane Modulates Endothelial Permeability

publication Evidence: moderate

Author Information

Author(s): J. M. Klausner, S. Abu-Abid, J. S. Alexander, R. Hanshke-Mineau, G. Goldman, N. Morel, C. R. Valeri, D. Shepro, H. B. Hechtman

Primary Institution: Tel Aviv Sourasky Medical Center, Tel Aviv University

Hypothesis

Does thromboxane directly modulate microvascular permeability in vitro?

Conclusion

Thromboxane directly modulates the permeability of endothelial cells in vitro.

Supporting Evidence

  • Thromboxane mimic increased permeability indicated by the passage of labeled albumin across endothelial cell monolayers.
  • Electron microscopy showed increased permeability based on wide interendothelial gap formation.
  • Tx receptor antagonist prevented thromboxane mimic-induced cytoskeletal changes.

Takeaway

Thromboxane is a substance that can make blood vessel walls leakier, which can be important for understanding certain health issues.

Methodology

The study used cultured bovine aortic endothelial cells to assess the effects of a thromboxane mimic on cell permeability and cytoskeletal changes.

Limitations

The study's findings may not directly apply to in vivo conditions due to the use of cultured cells.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication